Status:
UNKNOWN
Intravenous Infusion of Lidocaine in Colonoscopy
Lead Sponsor:
Shandong University
Conditions:
Sedation
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
intravenous infusion of lidocaine significantly reduce fatigue and pain and improve the patients satisfaction after sedation for colonoscopy.
Detailed Description
This study divide patients into two groups, lidocaine group one will be given lidocaine intravenously; control group will be given saline . the difference between patients fatigue and pain will be com...
Eligibility Criteria
Inclusion
- patients aged \>18 years who were scheduled for colonscopy at Qilu hospital.
Exclusion
- patients with ASA (American Society of Anesthesiologists) Class 4 or 5, pre-existing hypoxemia (SpO2 \<90%), hypotension (systolic blood pressure \<90 mm Hg), bradycardia (HR\<50 beats/min), uncontrolled hypertension (SBP \>170 mm Hg, diastolic blood pressure\>100 mm Hg), severe renal or liver failure, pregnancy or lactation, allergy to lidocaine, atrioventricular block, epilepsy, and inability to give informed consen
- \-
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04439786
Start Date
July 1 2020
End Date
December 31 2020
Last Update
June 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012